metastatic colorectal cancer

基本解釋

• 轉(zhuǎn)移性結(jié)直腸癌

英漢例句

雙語例句

• It is therefore important to identify prognostic factors for metastatic colorectal cancer patients.
  因此，為轉(zhuǎn)移的大腸直腸癌病患確認(rèn)預(yù)后的因子是重要的。
• It first received approval from the U.S. Food and Drug Administration in 2004 to treat metastatic colorectal cancer.
  它最初是在2004年經(jīng)美國食品和藥物管理局獲得批準(zhǔn)，用以治療轉(zhuǎn)移性大腸直腸癌。
• OBJECTIVE To evaluate the efficacy and safety of bevacizumab when added to first-line irinotecan-based chemotherapy in patients with metastatic colorectal cancer.
  目的觀察貝伐單抗與化療藥物聯(lián)合用于晚期結(jié)直腸癌一線治療的近期療效和安全性。

權(quán)威例句

• On April 29, 2011, the drug was approved for the treatment of advanced metastatic colorectal cancer.
  FORBES: Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

• metastatic colorectal cancer更多例句

詞組短語

短語

• metastatic colorectal cancer mCRC 轉(zhuǎn)移性結(jié)直腸癌

• metastatic colorectal cancer更多詞組

專業(yè)釋義

醫(yī)藥科學(xué)

• 轉(zhuǎn)移性大腸癌

  Objective: To evaluate the efficacy and safety of Calcium levofolinate (L-CF) plus 5-fluorouracil(5-Fu) and oxaliplatin(L-OHP) by comparing with Calcium folinate (CF) plus 5-Fu and L-OHP for patients with metastatic colorectal cancer.
  目的：通過對(duì)照亞葉酸鈣(CF)，評(píng)價(jià)左亞葉酸鈣(L-CF)聯(lián)合5-氟尿嘧啶(5-FU)和奧沙利鉑(L-OHP)治療轉(zhuǎn)移性大腸癌的有效性與安全性。